You just read:

Glenmark Pharmaceuticals Initiates Clinical Investigation for GBR 310, its Proposed Biosimilar Candidate for XOLAIR®

News provided by

Glenmark Pharmaceuticals

Apr 25, 2017, 08:00 ET